Skip to main content
Top
Published in: Comparative Hepatology 1/2004

Open Access 01-01-2004 | Proceedings

Precision-cut liver slices in culture as a tool to assess the physiological involvement of Kupffer cells in hepatic metabolism

Authors: Audrey M Neyrinck, Cristina Gomez, Nathalie M Delzenne

Published in: Comparative Hepatology | Special Issue 1/2004

Login to get access

Excerpt

Hepatic macrophages have the capacity to secrete a tremendous array of molecules, which can be divided into 3 categories é cytokines (TNF-alpha), lipid mediators (prostaglandins PGE2) and reactive intermediates (NOé) é in response to stimulus, such as lipopolysaccharides (LPS) [1, 2]. Such mediators are capable to modulate both the metabolism and the integrity of hepatocytes in vitro [2]. The physiological role of Kupffer cell in hepatic metabolism regulation has been approached in the present study by using the original in vitro model of precision-cut liver slices (PCLS) in culture; this model allows preserving the liver lobule architecture, by maintaining namely cell diversity in physiological proportion and cell-cell interactions [3]. First, we established whether non-parenchymal cells are still viable in rat PCLS and are able to respond to LPS in vitro; TNF-alpha, PGE2, NOx (reflecting NOé release) were measured in the incubation medium of PCLS from rats previously treated with GdCl3 é a specific inhibitor of Kupffer cell phagocytosis [4] é or NaCl as a control- in order to evaluate the contribution of Kupffer cell in mediator release. Moreover, by using the same model, we have investigated the role of Kupffer cell in the regulation of lipid synthesis in PCLS, in order to approach the biochemical mechanism explaining our last results, which indicate that the inhibition of Kupffer cell by GdCl3 leads to triglycerides accumulation in liver tissue [5]. …
Literature
1.
go back to reference Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 1990, 192: 245-261. 10.1111/j.1432-1033.1990.tb19222.x.CrossRefPubMed Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 1990, 192: 245-261. 10.1111/j.1432-1033.1990.tb19222.x.CrossRefPubMed
2.
go back to reference Laskin DL, Pendino KJ: Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol. 1995, 35: 655-677. 10.1146/annurev.pa.35.040195.003255.CrossRefPubMed Laskin DL, Pendino KJ: Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol. 1995, 35: 655-677. 10.1146/annurev.pa.35.040195.003255.CrossRefPubMed
3.
go back to reference C Lerche-Langrand, Toutain HJ: Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology. 2000, 153: 221-253. 10.1016/S0300-483X(00)00316-4.CrossRef C Lerche-Langrand, Toutain HJ: Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology. 2000, 153: 221-253. 10.1016/S0300-483X(00)00316-4.CrossRef
4.
go back to reference Hardonk MJ, Dijkhuis FWJ, Hulstaert CE, Koudstaal J: Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol. 1992, 52: 296-302.PubMed Hardonk MJ, Dijkhuis FWJ, Hulstaert CE, Koudstaal J: Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol. 1992, 52: 296-302.PubMed
5.
go back to reference Neyrinck AM, Taper HS, Delzenne NM: Gadolinium chloride does not block the hypertriglyceridemia induced by LPS administration to rats. In: Cells of the Hepatic sinusoid. Edited by: Wisse E, Knook DL, de Zanger R, Fraser R. 2001, Kupffer Cell Foundation, Leiden, 8: 30-33. Neyrinck AM, Taper HS, Delzenne NM: Gadolinium chloride does not block the hypertriglyceridemia induced by LPS administration to rats. In: Cells of the Hepatic sinusoid. Edited by: Wisse E, Knook DL, de Zanger R, Fraser R. 2001, Kupffer Cell Foundation, Leiden, 8: 30-33.
6.
go back to reference Neyrinck AM, Taper HS, Gevers V, Declerck B, Delzenne NM: Inhibition of Kupffer cell activity induces hepatic triglyceride synthesis in fasted rats, independent of lipopolysaccharide challenge. J Hepatol. 2002, 36: 466-473. 10.1016/S0168-8278(02)00009-0.CrossRefPubMed Neyrinck AM, Taper HS, Gevers V, Declerck B, Delzenne NM: Inhibition of Kupffer cell activity induces hepatic triglyceride synthesis in fasted rats, independent of lipopolysaccharide challenge. J Hepatol. 2002, 36: 466-473. 10.1016/S0168-8278(02)00009-0.CrossRefPubMed
7.
go back to reference Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA: Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol. 1997, 121: 125-133. 10.1038/sj.bjp.0701100.PubMedCentralCrossRefPubMed Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA: Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol. 1997, 121: 125-133. 10.1038/sj.bjp.0701100.PubMedCentralCrossRefPubMed
8.
go back to reference Folch J, Lee M, Sloane-Standley G: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957, 226: 497-509.PubMed Folch J, Lee M, Sloane-Standley G: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957, 226: 497-509.PubMed
9.
go back to reference Liao W, Florén CH: Upregulation of low density lipoprotein receptor activity by TNF, a process of TNF-induced lipid synthesis and secretion. Lipids. 1994, 29: 679-684. 10.1007/BF02538911.CrossRefPubMed Liao W, Florén CH: Upregulation of low density lipoprotein receptor activity by TNF, a process of TNF-induced lipid synthesis and secretion. Lipids. 1994, 29: 679-684. 10.1007/BF02538911.CrossRefPubMed
10.
go back to reference Roland CR, Naziruddin B, Mohanakumar T, Flye MW: Gadolinium chloride inhibits Kupffer cell nitric oxide synthase (iNOS) induction. J Leukoc Biol. 1996, 60: 487-492.PubMed Roland CR, Naziruddin B, Mohanakumar T, Flye MW: Gadolinium chloride inhibits Kupffer cell nitric oxide synthase (iNOS) induction. J Leukoc Biol. 1996, 60: 487-492.PubMed
11.
go back to reference Coleman RA, Smith WL, Narumiya S: International union of pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacological Reviews. 1994, 46: 205-229.PubMed Coleman RA, Smith WL, Narumiya S: International union of pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacological Reviews. 1994, 46: 205-229.PubMed
12.
go back to reference Casteleijn E, Kuiper J, Van Rooij HC, Koster JF, Van Berckel TJ: Conditioned media of Kupffer and endothelial cells influence protein phosphorylation in parenchymal liver cells. Involvement of prostaglandins. Biochem J. 1988, 252: 601-605.PubMedCentralCrossRefPubMed Casteleijn E, Kuiper J, Van Rooij HC, Koster JF, Van Berckel TJ: Conditioned media of Kupffer and endothelial cells influence protein phosphorylation in parenchymal liver cells. Involvement of prostaglandins. Biochem J. 1988, 252: 601-605.PubMedCentralCrossRefPubMed
Metadata
Title
Precision-cut liver slices in culture as a tool to assess the physiological involvement of Kupffer cells in hepatic metabolism
Authors
Audrey M Neyrinck
Cristina Gomez
Nathalie M Delzenne
Publication date
01-01-2004
Publisher
BioMed Central
Published in
Comparative Hepatology / Issue Special Issue 1/2004
Electronic ISSN: 1476-5926
DOI
https://doi.org/10.1186/1476-5926-2-S1-S45

Other articles of this Special Issue 1/2004

Comparative Hepatology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.